The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
A Structure-Based Drug Discovery Paradigm
Open accessAbstract
Structure-based drug design is becoming an essential tool for faster and more cost-efficient lead discovery relative to the traditional method. Genomic, proteomic, and structural studies have provided hundreds of new targets and opportunities for future drug discovery. This situation poses a major problem: the necessity to handle the “big data” generated by combinatorial chemistry. Artificial intelligence (AI) and deep learning play a pivotal role in the analysis and systemization of larger data sets by statistical machine learning methods. Advanced AI-based sophisticated machine learning tools have a significant impact on the drug discovery process including medicinal chemistry. In this review, we focus on the currently available methods and algorithms for structure-based drug design including virtual screening and de novo drug design, with a special emphasis on AI- and deep-learning-based methods used for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Machine learning for molecular and materials science
Butler, K. T., Davies, D. W., Cartwright, H., Isayev, O., & Walsh, A. (2018) · Nature · doi:10.1038/s41586-018-0337-2 · Cited by 4,968 · cited 1×
“In a GAN (Figure 3), two ANN models—the generator and discriminator—are trained simultaneously and generate a new molecule from scratch by optimizing a different and opposing objective function in a zero-sum game [123].”
BackgroundDocking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,827
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D., & Karplus, K. (2009) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22570 · Cited by 1,409
Molecular de-novo design through deep reinforcement learning
Olivecrona, M., Blaschke, T., Engkvist, O., & Chen, H. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0235-x · Cited by 1,324
Protein structure homology modeling using SWISS-MODEL workspace
Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., & Schwede, T. (2009) · Nature Protocols · doi:10.1038/nprot.2008.197 · Cited by 1,229
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Lionta, E., Spyrou, G., Vassilatis, D., & Cournia, Z. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929124445 · Cited by 1,165
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · cited 1×
“[118] applied a DNN and showed better performance as compared to RF on 13 of the total 15 targets.”
MethodDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
Laurie, A. T. R., & Jackson, R. M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti315 · Cited by 1,047
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
Protein–ligand docking: Current status and future challenges
Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21082 · Cited by 1,004
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939
Comparative evaluation of 11 scoring functions for molecular docking.
Wang, R., Lu, Y., & Wang, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203783 · Cited by 849
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
Wlodawer, A., & Vondrasek, J. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.249 · Cited by 734
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach
Kapetanovic, I. M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.006 · Cited by 662
A review of protein-small molecule docking methods
Taylor, R. D., Jewsbury, P. J., & Essex, J. W. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020155510718 · Cited by 655
Advances and Challenges in Protein-Ligand Docking
Huang, S.-Y., & Zou, X. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11083016 · Cited by 639
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9322-0 · Cited by 574
Byvatov, E., Fechner, U., Sadowski, J., & Schneider, G. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0341161 · Cited by 565
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546 · cited 1×
“, a UK-based world class AI-driven drug design company [93] is collaborating with Sanofi to find a cure for metabolic disorders [94], and Clegene, another leading pharmaceutical company, aims to accelerate drug discovery in the areas of autoimmunity and oncology [95].”
BackgroundMoitessier, N., Englebienne, P., Lee, D., Lawandi, J., & Corbeil, C. R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707515 · Cited by 514
Comparative Assessment of Scoring Functions on a Diverse Test Set
Cheng, T., Li, X., Li, Y., Liu, Z., & Wang, R. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9000053 · Cited by 513
Huang, S.-Y., Grinter, S. Z., & Zou, X. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp00151a · Cited by 508
Assessing Scoring Functions for Protein−Ligand Interactions
Ferrara, P., Gohlke, H., Price, D. J., Klebe, G., & Brooks, C. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030489h · Cited by 481
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Ghosh, A. K., Osswald, H. L., & Prato, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01697 · Cited by 419
Boosting docking-based virtual screening with deep learning.
Pereira, J. C., Caffarena, E. R., & dos Santos, C. N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00355 · Cited by 395
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Putin, E., Asadulaev, A., Ivanenkov, Y., Aladinskiy, V., Sanchez-Lengeling, B., Aspuru-Guzik, A., & Zhavoronkov, A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 372
Ain, Q. U., Aleksandrova, A., Roessler, F. D., & Ballester, P. J. (2015) · WIREs Computational Molecular Science · doi:10.1002/wcms.1225 · Cited by 357
Moore, T. J., Zhang, H., Anderson, G., & Alexander, G. C. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.3931 · Cited by 356
Active Learning with Support Vector Machines in the Drug Discovery Process
Warmuth, M. K., Liao, J., Rätsch, G., Mathieson, M., Putta, S., & Lemmen, C. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025620t · Cited by 354
Virtual Screening in Drug Discovery - A Computational Perspective
Reddy, A. S., Pati, S. P., Kumar, P. P., Pradeep, H. N., & Sastry, G. N. (2007) · Current Protein & Peptide Science · doi:10.2174/138920307781369427 · Cited by 350
Recent advances in computer-aided drug design
Song, C. M., Lim, S. J., & Tong, J. C. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp023 · Cited by 344
Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01089 · Cited by 331
How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment
Wang, R., & Wang, S. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010025x · Cited by 311
Mandal, S., Moudgil, M., & Mandal, S. K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.065 · Cited by 303
Muegge, I. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050038s · Cited by 303
Structure-based drug design to augment hit discovery
Kalyaanamoorthy, S., & Chen, Y.-P. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.006 · Cited by 296
Editorial: Artificial Neural Networks as Models of Neural Information Processing
van Gerven, M., & Bohte, S. (2017) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2017.00114 · Cited by 278
Flexible ligand docking using a genetic algorithm
Oshiro, C. M., Kuntz, I. D., & Dixon, J. S. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124402 · Cited by 275
Virtual Screening of Molecular Databases Using a Support Vector Machine
Jorissen, R. N., & Gilson, M. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049641u · Cited by 258
Hit discovery and hit-to-lead approaches
Keserű, G. M., & Makara, G. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.016 · Cited by 256
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Artificial Intelligence Approaches for Rational Drug Design and Discovery
Duch, W., Swaminathan, K., & Meller, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765954 · Cited by 243
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
Martin, Y. C. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9303-2 · Cited by 237 · cited 1×
“Availability of limited experimental data and reliable output of computational methods cause researchers to ignore tautomerization, but they are still irresistible [10,132].”
BackgroundAn application of machine learning to haematological diagnosis
Gunčar, G., Kukar, M., Notar, M., Brvar, M., Černelč, P., Notar, M., & Notar, M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18564-8 · Cited by 237
A multiple‐start Monte Carlo docking method
Hart, T. N., & Read, R. J. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340130304 · Cited by 227
Evaluating research: A multidisciplinary approach to assessing research practice and quality
Mårtensson, P., Fors, U., Wallin, S., Zander, U., & Nilsson, G. H. (2015) · Research Policy · doi:10.1016/j.respol.2015.11.009 · Cited by 227
In silico methods to address polypharmacology: current status, applications and future perspectives
Lavecchia, A., & Cerchia, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.007 · Cited by 225
Wang, R., Lu, Y., Fang, X., & Wang, S. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049733j · Cited by 224
Bishop, C. M. (2013) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2012.0222 · Cited by 211
Zernov, V. V., Balakin, K. V., Ivaschenko, A. A., Savchuk, N. P., & Pletnev, I. V. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0340916 · Cited by 209
Reviews Of Anti‐infective Agents: Maraviroc: The First of a New Class of Antiretroviral Agents
MacArthur, R. D., & Novak, R. M. (2008) · Clinical Infectious Diseases · doi:10.1086/589289 · Cited by 207
Urwyler, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.002501 · Cited by 207
Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
Hughes, T. B., Miller, G. P., & Swamidass, S. J. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00131 · Cited by 203
Data integration: challenges for drug discovery
Searls, D. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1608 · Cited by 198
The de novo design of protein structures
Richardson, J. S., & Richardson, D. C. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90070-4 · Cited by 184
Research on Big Data – A systematic mapping study
Akoka, J., Comyn-Wattiau, I., & Laoufi, N. (2017) · Computer Standards & Interfaces · doi:10.1016/j.csi.2017.01.004 · Cited by 178
Artificial Intelligence in Drug Discovery
Sellwood, M. A., Ahmed, M., Segler, M. H., & Brown, N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0212 · Cited by 173
High-throughput organ-on-a-chip systems: Current status and remaining challenges
Probst, C., Schneider, S., & Loskill, P. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.02.004 · Cited by 171
Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Lopez-Vallejo, F., Caulfield, T., Martinez-Mayorga, K., A. Giulianotti, M., Nefzi, A., A. Houghten, R., & L. Medina-Franco, J. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795767866 · Cited by 170
Hartenfeller, M., & Schneider, G. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_12 · Cited by 165
Topical Dorzolamide for the Treatment of Cystoid Macular Edema in Patients With Retinitis Pigmentosa
Grover, S., Apushkin, M. A., & Fishman, G. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.12.030 · Cited by 165
Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
Wilson, G. L., & Lill, M. A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.18 · Cited by 161
Nieto-Draghi, C., Fayet, G., Creton, B., Rozanska, X., Rotureau, P., de Hemptinne, J.-C., Ungerer, P., Rousseau, B., & Adamo, C. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00215 · Cited by 160
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection
Barmania, F., & Pepper, M. S. (2013) · Applied & Translational Genomics · doi:10.1016/j.atg.2013.05.004 · Cited by 159
Artificial Neural Networks as Models of Neural Information Processing
Gerven, M. V., & Bohté, S. M. (2018) · Frontiers research topics · doi:10.3389/978-2-88945-401-3 · Cited by 155
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
Identification of a New Series of STAT3 Inhibitors by Virtual Screening
Matsuno, K., Masuda, Y., Uehara, Y., Satō, H., Muroya, A., Takahashi, O., Yokotagawa, T., Furuya, T., Okawara, T., Otsuka, M., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000273 · Cited by 150
Data-driven medicinal chemistry in the era of big data
Lusher, S. J., McGuire, R., van Schaik, R. C., Nicholson, C. D., & de Vlieg, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.004 · Cited by 150
AI-powered drug discovery captures pharma interest
Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt0717-604 · Cited by 149
Huang, S., & Zou, X. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9002987 · Cited by 143
Ligand–receptor interaction platforms and their applications for drug discovery
Ye, F. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.715631 · Cited by 130
Application of computational methods for anticancer drug discovery, design, and optimization
Prada‐Gracia, D., Huerta‐Yépez, S., & Moreno‐Vargas, L. M. (2016) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2016.10.006 · Cited by 119
What has computer-aided molecular design ever done for drug discovery?
Clark, D. E. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.2.103 · Cited by 113
High-throughput andin silicoscreenings in drug discovery
Phatak, S. S., STEPHAN, C. C., & Cavasotto, C. N. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903190961 · Cited by 112
Chemical Space Mimicry for Drug Discovery
Yuan, W., Jiang, D., Nambiar, D. K., Liew, L. P., Hay, M. P., Bloomstein, J. D., Lu, P., Turner, B. E., Le, Q., Tibshirani, R. J., et al. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00754 · Cited by 97
Han, L., Ma, X. H., Lin, H., Jia, J., Zhu, F., Xue, Y. W., Li, Z., Cao, Z. W., Ji, Z., & Chen, Y. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.12.002 · Cited by 83
Big data: Some statistical issues
Cox, D. R., Kartsonaki, C., & Keogh, R. H. (2018) · Statistics & Probability Letters · doi:10.1016/j.spl.2018.02.015 · Cited by 83
Ma, X., Jia, J., Zhu, F., Xue, Y. W., Li, Z., & Chen, Y. (2009) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620709788167944 · Cited by 80
Ren, J.-X., Li, L., Zheng, R., Xie, H., Cao, Z.-X., Feng, S., Pan, Y., Chen, X., Wei, Y.-Q., & Yang, S. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100464b · Cited by 77
Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma
Young, J. D., Cai, C., & Lu, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1798-2 · Cited by 77
Targeted scoring functions for virtual screening.
Seifert, M. H. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.013 · Cited by 76
Wang, L., Gu, Q., Zheng, X., Ye, J., Liu, Z., Li, J., Hu, X., Hagler, A. T., & Xu, J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400322j · Cited by 76
Rutenber, E. E., & Stroud, R. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00139-6 · Cited by 67
The computational solution of optimal control problems with time lag
Dreyfus, S. E. (1973) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1973.1100330 · Cited by 59
Proteasome Inhibitors with Pyrazole Scaffolds from Structure-Based Virtual Screening
Miller, Z. C., Kim, K.-S., Lee, D.-M., Kasam, V., Baek, S. E., Lee, K. H., Zhang, Y., Ao, L., Carmony, K. C., Lee, N., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501344n · Cited by 57
Li, H., Peng, J., Leung, Y., Leung, K., Wong, M., Lü, G., & Ballester, P. J. (2018) · Biomolecules · doi:10.3390/biom8010012 · Cited by 57
A very short history of structure-based design: how did we get here and where do we need to go?
Blaney, J. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9518-x · Cited by 54
The rise and fall of machine learning methods in biomedical research
Koohy, H. (2017) · F1000Research · doi:10.12688/f1000research.13016.2 · Cited by 49
Virtual Screening of Abl Inhibitors from Large Compound Libraries by Support Vector Machines
Liu, X., H., X., Tan, C., Jiang, Y., Go, M., Low, B. C., & Chen, Y. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900135u · Cited by 45
New directions in library design and analysis
Gillet, V. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.015 · Cited by 44
Dadashpour, S., Küçükkılınç, T. T., Tan, O. Ü., Ozadali‐Sari, K., Irannejad, H., & Emami, S. (2015) · Archiv der Pharmazie · doi:10.1002/ardp.201400400 · Cited by 40
Computational Intelligence Methods for Docking Scores
Hecht, D., & Fogel, G. B. (2009) · Current Computer - Aided Drug Design · doi:10.2174/157340909787580863 · Cited by 40
Raub, S., Steffen, A., Kämper, A., & Marian, C. M. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004669 · Cited by 40
The emerging role of cloud computing in molecular modelling
Ebejer, J.-P., Fulle, S., Morris, G. M., & Finn, P. W. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.06.002 · Cited by 36
Mind the Gap! A Journey towards Computational Toxicology
Mangiatordi, G. F., Alberga, D., Altomare, C., Carotti, A., Catto, M., Cellamare, S., Gadaleta, D., Lattanzi, G., Leonetti, F., Pisani, L., et al. (2016) · Molecular Informatics · doi:10.1002/minf.201501017 · Cited by 30
Potapov, V., Cohen, M., Inbar, Y., & Schreiber, G. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-374 · Cited by 28
The business impact of deep learning
Howard, J. (2013) · ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/2487575.2491127 · Cited by 24
Pedretti, A., Mazzolari, A., Gervasoni, S. I., & Vistoli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092060 · Cited by 23
What Can Big Data on Academic Interest Reveal about a Drug? Reflections in Three Major US Databases
Kissin, I. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.12.005 · Cited by 13
Identification of druggable genome in staphylococcus aureus multidrug resistant strain
Batool, M., & Choi, S. (2017) · IEEE Life Sciences Conference (LSC) · doi:10.1109/lsc.2017.8268195 · Cited by 7
Self-citation
Research works printed but not linked: 8
- 2007, Drug evaluation: Prx-00023, a selective 5-ht1a receptor agonist for depression, Curr. Opin. Investig. Drugs, 8, 78
- Grant, 2009, Protein structure prediction in structure-based ligand design and virtual screening, Comb. Chem. High Throughput Screen., 12, 940, 10.2174/138620709789824718 · doi:10.2174/138620709789824718
- Lameijer, 2007, Designing active template molecules by combining computational de novo design and human chemist’s expertise, J. Med. Chem, 50, 1925, 10.1021/jm061356+ · doi:10.1021/jm061356+
- Tang, 2006, New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery, Drug Discov. Today Technol., 3, 307, 10.1016/j.ddtec.2006.09.004 · doi:10.1016/j.ddtec.2006.09.004
- Roy, K. (2019). Chapter 2—computational drug design methods—current and future perspectives. In silico drug design, Academic Press.
- Secchi, 2018, On the role of statistics in the era of big data: A call for a debate, Stat. Probab. Lett., 136, 10, 10.1016/j.spl.2018.02.041 · doi:10.1016/j.spl.2018.02.041
- Kuritzkes, 2008, Maraviroc, Nat. Rev. Drug Discov., 7, 15, 10.1038/nrd2490 · doi:10.1038/nrd2490
- Suthaharan, S. (2016). Support vector machine. Machine Learning Models and Algorithms for Big Data Classification: Thinking with Examples for Effective Learning, Springer US.
Cited by
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1061 · Cited by 7,850
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Targeting RNA structures with small molecules
Childs-Disney, J. L., Yang, X., Gibaut, Q. M. R., Tong, Y., Batey, R. T., & Disney, M. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00521-4 · Cited by 587
Chai-1: Decoding the molecular interactions of life
Discovery, C., Boitreaud, J., Dent, J., McPartlon, M., Meier, J., Reis, V., Rogozhnikov, A., & Wu, K. (2024) · doi:10.1101/2024.10.10.615955 · Cited by 517
Metadata
- Authors
- Batool, M., Ahmad, B., & Choi, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-06-06
- Volume
- 20
- Issue
- 11
- Pages
- 2783
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2948831670
- Cited by
- 744
- References
- 121
- FWCI
- 41.25
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Research Foundation of Korea (2019R1H1A2039674)
- Ministry of Science and ICT (2018K000369)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.